Jason Li works across cardio-oncology and immuno-oncology, characterizing therapy-associated pericardial disease, synthesizing evidence on malignant effusions, harmonizing biomarker diagnostics, and examining radioimmunotherapy mechanisms. He integrates clinical analyses and systematic reviews to inform safer, more effective cancer care.